Role of Social Determinants of Health in COVID-19 Recovery
This qualitative study explores how patients with COVID-19 and their caregivers perceive the role of social determinants of health in their recovery from COVID-19.
Related Articles
Declaration of Helsinki—Revisions for the 21st Century
This Viewpoint discusses significant revisions in the Declaration of Helsinki in response to changing ethical norms and technologies.
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults
This nonrandomized clinical trial evaluates a risk-stratified, response-adapted, transplant-free approach for treatment of children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma with…
Uptake of Maternal RSV Vaccination and Infant Nirsevimab
This cohort study examines uptake of maternal respiratory syncytial virus (RSV) vaccination and infant receipt of nirsevimab during the early period of availability for these…
Family Physicians See Culture Improve, Challenge RVU System
Family physicians saw improvements in workplace culture but questioned the effectiveness of RVU metrics to measure productivity.
Here’s how small Nvidia’s $3,000 Digits supercomputer looks in person
Another great-looking small computer.
Digital health investors predict uptick in M&A for 2025
Investors are optimistic about the potential for mergers, acquisitions and initial public offerings in 2025.
‘Multiverse simulation engine’ predicts every possible future to train humanoid robots and self-driving cars
Nvidia’s Cosmos platform lets researchers simulate multiple different realities and simulate real-world physics to generate footage that can train future robots.
Revisions to the Declaration of Helsinki on Its 60th Anniversary
This Viewpoint discusses the 2024 revisions made to the Declaration of Helsinki as it continues to work toward ensuring research is subject to ethical standards…
Academic Detailing Interventions and Evidence-Based Prescribing
This systematic review examines academic detailing programs targeted at improving prescribing behavior and describes program aspects associated with positive outcomes.
Scribe Therapeutics becomes latest CRISPR company to announce layoffs
Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR therapies.
